These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7002387)

  • 1. An in vitro assessment of cellular and humoral immune function in pulmonary tuberculosis: correction of defective neutrophil motility by ascorbate, levamisole, metoprolol and propranolol.
    Gatner EM; Anderson R
    Clin Exp Immunol; 1980 May; 40(2):327-35. PubMed ID: 7002387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of increasing weekly doses of ascorbate on certain cellular and humoral immune functions in normal volunteers.
    Anderson R; Oosthuizen R; Maritz R; Theron A; Van Rensburg AJ
    Am J Clin Nutr; 1980 Jan; 33(1):71-6. PubMed ID: 7355784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro evaluation of certain neutrophil and lymphocyte functions following the ingestion of 150 mg oral dose of levamisole: assessment of the extent and duration of stimulation of neutrophil chemotaxis, protein iodination and lymphocyte transformation.
    Anderson R; Oosthuizen R; Theron A; Van Rensburg AJ
    Clin Exp Immunol; 1979 Mar; 35(3):478-83. PubMed ID: 455786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and humoral immunity to purified protein derivative (PPD) in PPD skin reactive and nonreactive patients with pulmonary tuberculosis: comparative analysis of antigen-specific lymphocyte proliferation and IgG antibodies.
    Boras Z; Juretić A; Rudolf M; Uzarević B; Trescec A
    Croat Med J; 2002 Jun; 43(3):301-5. PubMed ID: 12035136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ascorbate on cellular humoral immunity in asthmatic children.
    Anderson R; Hay I; van Wyk H; Oosthuizen R; Theron A
    S Afr Med J; 1980 Dec; 58(24):974-7. PubMed ID: 7444701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro effects of propranolol and atenolol on neutrophil motility and post-phagocytic metabolic activity.
    Anderson R; van Rensburg AJ
    Immunology; 1979 May; 37(1):15-24. PubMed ID: 223974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased leucoattractant binding and reversible inhibition of neutrophil motility mediated by the peroxidase/H2O2/halide system: effects of ascorbate, cysteine, dithiothreitol, levamisole and thiamine.
    Anderson R; Jones PT
    Clin Exp Immunol; 1982 Feb; 47(2):487-96. PubMed ID: 7075031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorph function and cellular immunity in Nigerians with pulmonary tuberculosis.
    Onyemelukwe GC; Gupta R
    Afr J Med Med Sci; 1997; 26(1-2):23-6. PubMed ID: 10895223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil function in surgical patients: in vitro correlation of abnormal neutrophil chemotaxis by Levamisole.
    Christou NV; Meakins JL
    Surgery; 1979 May; 85(5):543-8. PubMed ID: 432816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils.
    Anderson R; Glover A; Koornhof HJ; Rabson AR
    J Immunol; 1976 Aug; 117(2):428-32. PubMed ID: 181491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of normal and abnormal neutrophil motility in vitro by dexpropranolol, metoprolol and sotalol.
    Anderson R
    S Afr Med J; 1979 Aug; 56(5):165. PubMed ID: 550459
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of phagocyte functions, inflammatory lymphokine activities and in vitro antibody synthesis in patients with active and chronic pulmonary tuberculosis.
    Antonaci S; Jirillo E; Polignano A; Ventura MT; Sabato R; Bonomo L
    Cytobios; 1991; 67(270-271):135-44. PubMed ID: 1800021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective neutrophil motility and recurrent infection. In vitro and in vivo effects of levamisole.
    Rabson AR; Anderson R; Glover A
    Clin Exp Immunol; 1978 Jul; 33(1):142-9. PubMed ID: 709909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of some immunological parameters in pulmonary tuberculosis].
    Dubaniewicz A; Sztaba-Kania M; Hoppe A
    Pol Merkur Lekarski; 2004 Feb; 16(92):123-7. PubMed ID: 15176294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of levamisole on normal and abnormal leukocyte locomotion.
    Wright DG; Kirkpatrick CH; Gallin JI
    J Clin Invest; 1977 May; 59(5):941-50. PubMed ID: 192765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotactic function of polymorphonuclear leukocytes from patients with recurrent infections: partial correction by levamisole "in vitro".
    Stein AN; Díez RA; Sen L; Estévez ME
    Allergol Immunopathol (Madr); 1985; 13(2):127-34. PubMed ID: 4003229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ascorbate on leucocytes: Part III. In vitro and in vivo stimulation of abnormal neutrophil motility by ascorbate.
    Anderson R; Theron A
    S Afr Med J; 1979 Sep; 56(11):429-33. PubMed ID: 550365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of CD88 and associated impairment of complement 5a-induced neutrophil responses in human immunodeficiency virus type 1-infected patients with and without pulmonary tuberculosis.
    Meddows-Taylor S; Pendle S; Tiemessen CT
    J Infect Dis; 2001 Feb; 183(4):662-5. PubMed ID: 11170995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of leukocyte chemotaxis in various clinico-immunological situations].
    Suárez Saro JM; Laguna Martínez R; Callol Sánchez L; Caro de Miguel C; Gómez de Terrenos Sánchez FJ
    Allergol Immunopathol (Madr); 1985; 13(3):187-92. PubMed ID: 3898789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.